Earnings GuidanceThe second-quarter miss and downward revision to the company’s 2025 adjusted EPS guidance drove shares meaningfully lower.
Financial PerformanceInsperity's second-quarter gross profit of $223 million was $16 million below the estimate, dragged down by persistently higher-than-expected benefit costs.
Healthcare CostsHealthcare costs trended meaningfully higher, coming in $12 million above management’s forecast due to a combination of higher-than-expected pharmacy costs and claims incurred but not yet reported.